The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Anti-Müllerian Hormone Serum Concentrations in Normoovulatory and Anovulatory Women of Reproductive Age
Open accessAbstract
Anti-Müllerian hormone (AMH) concentrations correlate with the number of antral follicles as well as age and constitute an endocrine marker for ovarian aging. In normogonadotropic anovulatory infertile women [World Health Organization (WHO) class 2], the number of early antral follicles is usually increased. To investigate whether AMH concentrations are increased, serum levels in 128 WHO 2 women were compared with those in 41 normoovulatory premenopausal women of similar age. Serum AMH concentrations are significantly (P < 0.001) elevated in WHO 2 patients [median, 7.6 μg/liter (range, 0.1–40.0)], compared with controls [median, 2.1 μg/liter (0.1–7.4)]. In 106 patients presenting with polycystic ovaries (PCOs) (≥12 follicles/ovary measuring 2–9 mm and/or an ovarian volume > 10 ml), AMH levels were elevated [9.3 μg/liter (1.8–40.0)], compared with 22 patients without PCOs [6.4 μg/liter (0.1–22.1)] (P < 0.0001). In WHO 2 patients, AMH concentrations correlated with features characteristic for polycystic ovary syndrome such as LH concentrations (r = 0.331; P = 0.0001), testosterone levels (r = 0.477, P = 0.0001), mean ovarian volume (r = 0.421; P = 0.0001), and the number of ovarian follicles (r = 0.308; P = 0.0001). AMH levels correlated well with age in WHO 2 patients (r = −0.248; P = 0.002) as well as in controls (r = −0.465; P = 0.005). However, the relative decline in AMH with age is less pronounced in WHO 2 patients. In a subset of patients no significant correlation was found between AMH serum concentrations and the FSH response dose, the duration of stimulation, and the total number of ampoules of FSH used. In conclusion, serum AMH concentrations are elevated in WHO 2 women, especially in those patients exhibiting PCOs. Because AMH concentrations correlated well with other clinical, endocrine, and ultrasound markers associated with polycystic ovary syndrome, AMH may be used as a marker for the extent of the disease. A less pronounced AMH decrease over time in these women may suggest retarded ovarian aging. The latter hypothesis, however, should be confirmed by longitudinal studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cate, R. L., Mattaliano, R. J., Hession, C., Tizard, R., Farber, N. M., Cheung, A., Ninfa, E. G., Frey, A. Z., Gash, D. J., Chow, E. P., et al. (1986) · Cell · doi:10.1016/0092-8674(86)90783-x · Cited by 1,022
Control of Primordial Follicle Recruitment by Anti-Müllerian Hormone in the Mouse Ovary1
Durlinger, A. L. L., Kramer, P., Karels, B., de Jong, F. H., Uilenbroek, J. T. J., Grootegoed, J. A., & Themmen, A. P. N. (1999) · Endocrinology · doi:10.1210/endo.140.12.7204 · Cited by 1,011
Self-citationSerum anti-Mullerian hormone levels: a novel measure of ovarian reserve
van Rooij, I. A. J. (2002) · Human Reproduction · doi:10.1093/humrep/17.12.3065 · Cited by 951
Antimüllerian hormone serum levels: a putative marker for ovarian aging
de Vet, A., Laven, J. S. E., de Jong, F. H., Themmen, A. P. N., & Fauser, B. C. J. M. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02993-4 · Cited by 887
Self-citationRegulation of ovarian function: the role of anti-Mullerian hormone
Durlinger, A. L., Visser, J. A., & Themmen, A. P. (2002) · Reproduction · doi:10.1530/rep.0.1240601 · Cited by 779
Self-citationAnti-Mullerian Hormone Attenuates the Effects of FSH on Follicle Development in the Mouse Ovary
Durlinger, A. L. L., Gruijters, M. J. G., Kramer, P., Karels, B., Kumar, T. R., Matzuk, M. M., Rose, U. M., de Jong, F. H., Uilenbroek, J. T. J., Grootegoed, J. A., et al. (2001) · Endocrinology · doi:10.1210/en.142.11.4891 · Cited by 772
Self-citationFanchin, R. (2003) · Human Reproduction · doi:10.1093/humrep/deg042 · Cited by 624
Dahlgren, E., Johansson, S., Lindstedt, G., Knutsson, F., Oden, A., Janson, P., Mattson, L.-A., Crona, N., & Lundberg, P.-A. (1992) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(92)90704-m · Cited by 527
Seifer, D. B., MacLaughlin, D. T., Christian, B. P., Feng, B., & Shelden, R. M. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)03201-0 · Cited by 494
Münsterberg, A., & Lovell-Badge, R. (1991) · Development · doi:10.1242/dev.113.2.613 · Cited by 480
Cited by
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
Witchel, S. F., Oberfield, S., Rosenfield, R. L., Codner, E., Bonny, A., Ibáñez, L., Pena, A., Horikawa, R., Gomez-Lobo, V., Joel, D., et al. (2015) · Hormone Research in Paediatrics · doi:10.1159/000375530 · Cited by 3,113
Fauser, B. C. J. M., Tarlatzis, B. C., Rebar, R. W., Legro, R. S., Balen, A. H., Lobo, R., Carmina, E., Chang, J., Yildiz, B. O., Laven, J. S. E., et al. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.09.024 · Cited by 1,976
Self-citationAzziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., Lizneva, D., Natterson-Horowtiz, B., Teede, H. J., & Yildiz, B. O. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.57 · Cited by 2,005
Self-citationThe physiology and clinical utility of anti-Müllerian hormone in women
Dewailly, D., Andersen, C. Y., Balen, A., Broekmans, F., Dilaver, N., Fanchin, R., Griesinger, G., Kelsey, T. W., La Marca, A., Lambalk, C., et al. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmt062 · Cited by 1,049
Self-citationAnti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)
La Marca, A., Sighinolfi, G., Radi, D., Argento, C., Baraldi, E., Artenisio, A. C., Stabile, G., & Volpe, A. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmp036 · Cited by 956
Anti-Müllerian hormone: a new marker for ovarian function
Visser, J. A., de Jong, F. H., Laven, J. S. E., & Themmen, A. P. N. (2006) · Reproduction · doi:10.1530/rep.1.00529 · Cited by 799
Self-citationBalen, A. H., Morley, L. C., Misso, M., Franks, S., Legro, R. S., Wijeyaratne, C. N., Stener-Victorin, E., Fauser, B. C. J. M., Norman, R. J., & Teede, H. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmw025 · Cited by 705
Self-citationAnti-Müllerian hormone: ovarian reserve testing and its potential clinical implications
Broer, S. L., Broekmans, F. J. M., Laven, J. S. E., & Fauser, B. C. J. M. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu020 · Cited by 683
Self-citationThe polycystic ovary syndrome: a position statement from the European Society of Endocrinology
Conway, G., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Franks, S., Gambineri, A., Kelestimur, F., Macut, D., Micic, D., Pasquali, R., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0253 · Cited by 676
Update on PCOS: consequences, challenges, and guiding treatment
Hoeger, K. M., Dokras, A., & Piltonen, T. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa839 · Cited by 610
Follicle dynamics and anovulation in polycystic ovary syndrome
Franks, S., Stark, J., & Hardy, K. (2008) · Human Reproduction Update · doi:10.1093/humupd/dmn015 · Cited by 581
Dewailly, D., Lujan, M. E., Carmina, E., Cedars, M. I., Laven, J., Norman, R. J., & Escobar-Morreale, H. F. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmt061 · Cited by 551
Self-citationDewailly, D., Robin, G., Peigne, M., Decanter, C., Pigny, P., & Catteau-Jonard, S. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmw027 · Cited by 526
Polycystic Ovarian Syndrome: Correlation Between Hyperandrogenism, Insulin Resistance and Obesity.
Zeng, X., Xie, Y.-J., Liu, Y.-T., Long, S.-L., & Mo, Z.-C. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.11.003 · Cited by 525
Granulosa Cell Production of Anti-Müllerian Hormone Is Increased in Polycystic Ovaries
Pellatt, L., Hanna, L., Brincat, M., Galea, R., Brain, H., Whitehead, S., & Mason, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1582 · Cited by 521
Jonard, S. (2004) · Human Reproduction Update · doi:10.1093/humupd/dmh010 · Cited by 519
Dewailly, D., Gronier, H., Poncelet, E., Robin, G., Leroy, M., Pigny, P., Duhamel, A., & Catteau-Jonard, S. (2011) · Human Reproduction · doi:10.1093/humrep/der297 · Cited by 491
Qiao, J., & Feng, H. L. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmq032 · Cited by 479
Pigny, P., Jonard, S., Robert, Y., & Dewailly, D. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2076 · Cited by 471
A Validated Model of Serum Anti-Müllerian Hormone from Conception to Menopause
Kelsey, T. W., Wright, P., Nelson, S. M., Anderson, R. A., & Wallace, W. H. B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022024 · Cited by 457
Cimino, I., Casoni, F., Liu, X., Messina, A., Parkash, J., Jamin, S. P., Catteau-Jonard, S., Collier, F., Baroncini, M., Dewailly, D., et al. (2016) · Nature Communications · doi:10.1038/ncomms10055 · Cited by 404
Nelson, S. M., Yates, R. W., & Fleming, R. (2007) · Human Reproduction · doi:10.1093/humrep/dem204 · Cited by 391
La Marca, A., & Volpe, A. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02533.x · Cited by 369
Goodman, N. F., Cobin, R. H., Futterweit, W., Glueck, J. S., Legro, R. S., & Carmina, E. (2015) · Endocrine Practice · doi:10.4158/ep15748.dscpt2 · Cited by 359
Diagnostic evaluation of the infertile female: a committee opinion
(2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.03.019 · Cited by 337
Lauritsen, M. P., Bentzen, J. G., Pinborg, A., Loft, A., Forman, J. L., Thuesen, L. L., Cohen, A., Hougaard, D. M., & Nyboe Andersen, A. (2014) · Human Reproduction · doi:10.1093/humrep/det469 · Cited by 334
Anti-Mullerian hormone (AMH): what do we still need to know?
La Marca, A., Broekmans, F. J., Volpe, A., Fauser, B. C., Macklon, N. S., & on behalf of the ESHRE Special Interest Group for Reproductive Endocrinology - AMH Round Table (2009) · Human Reproduction · doi:10.1093/humrep/dep210 · Cited by 327
Self-citationAutophagy in ovary and polycystic ovary syndrome: role, dispute and future perspective
Kumariya, S., Ubba, V., Jha, R. K., & Gayen, J. R. (2021) · Autophagy · doi:10.1080/15548627.2021.1938914 · Cited by 305
Piltonen, T., Morin-Papunen, L., Koivunen, R., Perheentupa, A., Ruokonen, A., & Tapanainen, J. S. (2005) · Human Reproduction · doi:10.1093/humrep/deh850 · Cited by 294
Assessing ovarian response: antral follicle count versus anti-Müllerian hormone
Fleming, R., Seifer, D. B., Frattarelli, J. L., & Ruman, J. (2015) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2015.06.015 · Cited by 291
Iliodromiti, S., Kelsey, T. W., Anderson, R. A., & Nelson, S. M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1393 · Cited by 280
Pellatt, L., Rice, S., Dilaver, N., Heshri, A., Galea, R., Brincat, M., Brown, K., Simpson, E. R., & Mason, H. D. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.08.015 · Cited by 276
Rico, C., Fabre, S., Medigue, C., Clemente, N. D., Clement, F., Bontoux, M., Touze, J.-L., Dupont, M., Briant, E., Remy, B., et al. (2009) · Biology of Reproduction · doi:10.1095/biolreprod.108.072157 · Cited by 275
Serum Anti-Müllerian Hormone Levels in Healthy Females: A Nomogram Ranging from Infancy to Adulthood
Lie Fong, S., Visser, J. A., Welt, C. K., de Rijke, Y. B., Eijkemans, M. J. C., Broekmans, F. J., Roes, E. M., Peters, W. H. M., Hokken-Koelega, A. C. S., Fauser, B. C. J. M., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1440 · Cited by 259
Self-citationGenetics of polycystic ovary syndrome: searching for the way out of the labyrinth
Diamanti-Kandarakis, E., & Piperi, C. (2005) · Human Reproduction Update · doi:10.1093/humupd/dmi025 · Cited by 167
“Recent data have shown that overproduction of antimullerian factor (AMH) from GC in PCOS (Cook et al., 2002; De Vet et al., 2002; Pigny et al., 2003; Joop et al., 2004) could be implicated in hyperandrogenism, since a positive correlation has been found between AMH, T and androstenedione in PCOS…”
Lean polycystic ovary syndrome (PCOS): an evidence-based practical approach
Toosy, S., Sodi, R., & Pappachan, J. M. (2018) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-018-0371-5 · Cited by 154
Is foetal hyperexposure to androgens a cause of PCOS?
Filippou, P., & Homburg, R. (2017) · Human Reproduction Update · doi:10.1093/humupd/dmx013 · Cited by 152
The role of AMH in the pathophysiology of polycystic ovarian syndrome
Garg, D., & Tal, R. (2016) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2016.04.007 · Cited by 150
Is polycystic ovary syndrome an exception for reproductive aging?
Ramezani Tehrani, F., Solaymani-Dodaran, M., Hedayati, M., & Azizi, F. (2010) · Human Reproduction · doi:10.1093/humrep/deq088 · Cited by 111
Kristensen, S. L., Ramlau-Hansen, C. H., Ernst, E., Olsen, S. F., Bonde, J. P., Vested, A., & Toft, G. (2010) · Human Reproduction · doi:10.1093/humrep/deq273 · Cited by 102
Steegers-Theunissen, R. P. M., Wiegel, R. E., Jansen, P. W., Laven, J. S. E., & Sinclair, K. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218211 · Cited by 82
Self-citationRosenfield, R. L., Wroblewski, K., Padmanabhan, V., Littlejohn, E., Mortensen, M., & Ehrmann, D. A. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.03.059 · Cited by 80
Jamil, A. S., Alalaf, S. K., Al-Tawil, N. G., & Al-Shawaf, T. (2016) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-015-3889-5 · Cited by 73
Diagnosis of Polycystic Ovary Syndrome: AMH in combination with clinical symptoms
Sahmay, S., Aydin, Y., Oncul, M., & Senturk, L. M. (2014) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-013-0149-0 · Cited by 71
Clustering of PCOS-like traits in naturally hyperandrogenic female rhesus monkeys
Abbott, D. H., Rayome, B. H., Dumesic, D. A., Lewis, K. C., Edwards, A. K., Wallen, K., Wilson, M. E., Appt, S. E., & Levine, J. E. (2017) · Human Reproduction · doi:10.1093/humrep/dex036 · Cited by 66
Anti-Müllerian hormone in obese adolescent girls with polycystic ovary syndrome
Kim, J. Y., Tfayli, H., Michaliszyn, S. F., Lee, S., Nasr, A., & Arslanian, S. (2017) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2016.10.015 · Cited by 54
Early ovarian ageing: are women with polycystic ovaries protected?
Nikolaou, D., & Gilling-Smith, C. (2004) · Human Reproduction · doi:10.1093/humrep/deh419 · Cited by 46
Pinola, P., Morin-Papunen, L. C., Bloigu, A., Puukka, K., Ruokonen, A., Jarvelin, M. R., Franks, S., Tapanainen, J. S., & Lashen, H. (2014) · Human Reproduction · doi:10.1093/humrep/deu182 · Cited by 41
Erbb4 regulates the oocyte microenvironment during folliculogenesis
Veikkolainen, V., Ali, N., Doroszko, M., Kiviniemi, A., Miinalainen, I., Ohlsson, C., Poutanen, M., Rahman, N., Elenius, K., Vainio, S. J., et al. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa161 · Cited by 31
Tokmak, A., Timur, H., Aksoy, R. T., Çınar, M., & Yılmaz, N. (2015) · Journal of Turkish Society of Obstetric and Gynecology · doi:10.4274/tjod.21549 · Cited by 15
Metadata
- Authors
- Laven, J. S. E., Mulders, A. G. M. G. J., Visser, J. A., Themmen, A. P., de Jong, F. H., & Fauser, B. C. J. M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2004-01-01
- Volume
- 89
- Issue
- 1
- Pages
- 318-323
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2039487478
- Cited by
- 519
- References
- 40
- FWCI
- 19.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.